All Articles

A novel partnership aims to power a Newfoundland nickel mine with hydrogen generated from the mine's own rock, a first-of-its-kind model for green industry.

As the Pentagon scrambles for battle-tested autonomous weapons, a new partnership promises to deliver. But is fast-tracking foreign tech the answer or a risky bet?

Kymera Therapeutics' new lupus data isn't just about a drug. It's about a new strategy: erasing disease-causing proteins to build resilient value.

VENU's $50M sale-leaseback fuels a rapid expansion. But is its innovative financial model a new blueprint for growth or a high-stakes bet on the future?

A landmark study validates Ceribell's AI in predicting neurological outcomes, signaling a major shift in critical care and bolstering its competitive edge.

CAMIN’s appointment of Tom Parks as CFO is more than a personnel change. It's a clear signal of a strategic bet on technology to redefine a critical global industry.

Beyond a simple plea for donations, Héma-Québec is executing a sophisticated strategic campaign to secure Quebec's most vital, and volatile, supply chain.

Medtronic veteran Jesse Litwak joins ProVerum, a move signaling the BPH innovator is shifting from R&D to aggressive commercial scale-up with its new ProVee tech.

Calpine's new 25MW geothermal expansion at The Geysers provides baseload power for 25,000 homes, boosting California's grid and cementing Constellation's strategy.

Phenomenex, a Danaher company, launches its Luna Omega HILIC columns, aiming to simplify complex analysis in pharma, food safety, and diagnostics.

A key hospitality tech acquisition signals a major shift from fixing Wi-Fi problems to proactively validating the entire network, a move with broad implications.

With expanded coverage for 52 million Americans, Tonix Pharmaceuticals' TONMYA® is not just a drug launch; it's a market disruption for chronic pain.

Beyond the blowout earnings, Optical Cable Corp's Q2 results reveal a playbook for thriving in the digital infrastructure boom. Here's the strategic rationale.

Mineralys Therapeutics' Lorundrostat shows promise in reducing heart failure risk, a breakthrough for millions struggling with uncontrolled hypertension.

Beyond the gridlock in Meriden lies a story of strategic ambition. A look at how Parsons' engineering and a massive state investment aim to redefine a vital corridor.

Trane Technologies' latest report shows it's not just cutting emissions but building a profitable business model around it. A deep dive into their strategy.

Ares Capital, a giant in middle-market finance, just opened a new $1B funding spigot. Is this a blueprint for the BDC industry or a sign of cheaper capital for American businesses?

How new high-resolution analysis at Canadian GoldCamps' flagship project is de-risking a complex deposit and revealing its true high-grade potential.

With $173 million pouring into its tokenized SpaceX offering, MEXC is blurring the lines between crypto and Wall Street. But are retail investors buying a ticket to the moon or just a reflection of the rocket?

A routine board appointment at Bitcoin firm Twenty One Capital masks a major power shift. As Tether buys out SoftBank, is this a move toward legitimacy or a quiet coup?